Canada’s Top Consumer Products Stock to Own for Life

Canopy Growth Corp. (TSX:WEED)(NYSE:CGC) is a world-leading, diversified cannabis and cannabinoid-based consumer products company with operations in countries across the world.

| More on:
Marijuana plant and cannabis oil bottles isolated

Image source: Getty Images

Canopy Growth (TSX:WEED)(NYSE:CGC) is a world-leading, diversified cannabis and cannabinoid-based consumer products company with operations in countries across the world. The company produces, distributes, and sells a diverse range of cannabis and hemp-based products and other consumer products for both recreational and medical purposes under a portfolio of distinct brands in Canada. Canopy Growth sells products pursuant to the Cannabis Act, and globally pursuant to applicable international and Canadian legislation, regulations, and permits.

Impact of regulations regarding the distribution and sale of recreational cannabis

On October 17, 2018, the Cannabis Act came into effect in Canada, regulating both the medical and recreational cannabis markets in Canada and providing provincial, territorial, and municipal governments the authority to prescribe regulations regarding the distribution and sale of recreational cannabis. On October 17, 2019, the second phase of recreational cannabis products was legalized pursuant to certain amendments to the regulations under the Cannabis Act.

Product varieties and recreational cannabis products

Canopy Growth currently offers product varieties in dried flower, oil, softgels, vape pen power sources, pod-based vape devices, vape cartridges, cannabis-infused beverages, and cannabis-infused edibles, with product availability varying based on provincial and territorial regulations. Canopy Growth’s recreational cannabis products are predominantly sold to provincial and territorial agencies under a business-to-business wholesale model, with those provincial and territorial agencies then being responsible for the distribution of the company’s products to brick-and-mortar stores and for online retail sales.

Promoting brand awareness and driving consumer demand

In addition, Canopy Growth also operates a network of Tweed and Tokyo Smoke retail stores across Canada, where permissible, to promote brand awareness and drive consumer demand under a business-to-consumer model.

Diverse portfolio of medical cannabis products

Further, the company’s Spectrum Therapeutics medical division is a global leader in medical cannabis. Spectrum Therapeutics produces and distributes a diverse portfolio of medical cannabis products to healthcare practitioners and medical customers in Canada, and in several other countries where it is federally permissible to do so.

Expanding the company’s portfolio of medical cannabis offerings

In April 2019, Canopy Growth acquired C3 Cannabinoid Compound Company, Europe’s largest cannabinoid-based pharmaceuticals company and a leading manufacturer of dronabinol, a registered active pharmaceutical ingredient in Germany and certain other European countries. The addition of dronabinol has allowed Canopy Growth to expand the company’s portfolio of medical cannabis offerings for the company’s customers in Germany.

Investments in modernized manufacturing facilities

Subsequent to the passage, in December 2018, of the United States Agricultural Improvement Act of 2018, Canopy Growth began building the company’s hemp supply chain in the United States through the company’s investment in processing, extraction and finished goods manufacturing facilities. In September 2020, Canopy Growth’s Martha Stewart cannabidiol (CBD) line of premium quality, hemp-derived wellness gummies, oils, and softgels was launched in the United States.

Expanding the company’s product offering

In the fourth quarter of fiscal 2021, Canopy Growth expanded the company’s product offering to include CBD products for pets under the Martha Stewart CBD for Pet line and SurityPro, and a line of premium, ready-to-drink CBD-infused sparkling waters under the Quatreau brand.

Overall, Canopy Growth looks set to continue growing and creating value for shareholders.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

The Motley Fool has no position in any of the stocks mentioned. Fool contributor Nikhil Kumar has no position in any of the stocks mentioned. 

More on Cannabis Stocks

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Is Rising But I’m Worried About This One Thing

Canopy Growth stock is soaring as the legalization effort makes real progress in both Germany and the United States.

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Why Canopy Growth Stock Could Double in 2024

Canopy Growth (TSX:WEED) stock saw its share more than double in the last two weeks. So, can it do it…

Read more »

Coworkers standing near a wall
Cannabis Stocks

Why Is Everyone Talking About Canopy Growth Stock?

Canopy Growth stock (TSX:WEED) saw shares surge in the last two weeks for a variety of reasons investors can dig…

Read more »

Pot stocks are a riskier investment
Stocks for Beginners

Why Shares of Cannabis Stocks Are Rising This Week

Cannabis stocks received a boost this week as the White House urged the drug enforcement administration to reschedule the drug.

Read more »

A person holds a small glass jar of marijuana.
Stocks for Beginners

Why Canopy Growth Stock Jumped 16% on Wednesday

Canopy Growth stock (TSX:WEED) is up 16% on Wednesday, adding to a surge of 60% growth in the last week…

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Is the Worst Over for Canopy Growth Stock?

Down 99% from all-time highs Canopy Growth stock has burnt investor wealth and remains a high-risk investment.

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Steer Clear: This Stock Spells Trouble

A newly listed cannabis stock is outperforming in 2024 but investors should stay clear to avoid trouble and losses.

Read more »

Cannabis stocks have fallen.
Cannabis Stocks

2 Best Marijuana Stocks to Buy This Month

Marijuana stocks in the U.S. such as Green Thumb and Curaleaf can help you deliver outsized gains to investors in…

Read more »